The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Buprenorphine Transdermal Patches-Global Market Insights and Sales Trends 2024
Synopsis
The global Buprenorphine Transdermal Patches market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Buprenorphine Transdermal Patches in various end use industries. The expanding demands from the Relieve Cancer Pain and Other, are propelling Buprenorphine Transdermal Patches market. 5mcg/h, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 7.5mcg/h segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Buprenorphine Transdermal Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Buprenorphine Transdermal Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Buprenorphine Transdermal Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Buprenorphine Transdermal Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Buprenorphine Transdermal Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Buprenorphine Transdermal Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Buprenorphine Transdermal Patches covered in this report include Grunenthal, PurduePharma and Luye Pharma, etc.
The global Buprenorphine Transdermal Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grunenthal
PurduePharma
Luye Pharma
Global Buprenorphine Transdermal Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Buprenorphine Transdermal Patches market, Segment by Type:
5mcg/h
7.5mcg/h
10mcg/h
15 mcg/h
20 mcg/h
Global Buprenorphine Transdermal Patches market, by Application
Relieve Cancer Pain
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Buprenorphine Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Buprenorphine Transdermal Patches market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Buprenorphine Transdermal Patches in various end use industries. The expanding demands from the Relieve Cancer Pain and Other, are propelling Buprenorphine Transdermal Patches market. 5mcg/h, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 7.5mcg/h segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Buprenorphine Transdermal Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Buprenorphine Transdermal Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Buprenorphine Transdermal Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Buprenorphine Transdermal Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Buprenorphine Transdermal Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Buprenorphine Transdermal Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Buprenorphine Transdermal Patches covered in this report include Grunenthal, PurduePharma and Luye Pharma, etc.
The global Buprenorphine Transdermal Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grunenthal
PurduePharma
Luye Pharma
Global Buprenorphine Transdermal Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Buprenorphine Transdermal Patches market, Segment by Type:
5mcg/h
7.5mcg/h
10mcg/h
15 mcg/h
20 mcg/h
Global Buprenorphine Transdermal Patches market, by Application
Relieve Cancer Pain
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Buprenorphine Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Buprenorphine Transdermal Patches Market Overview
1.1 Buprenorphine Transdermal Patches Product Overview
1.2 Buprenorphine Transdermal Patches Market Segment by Type
1.2.1 5mcg/h
1.2.2 7.5mcg/h
1.2.3 10mcg/h
1.2.4 15 mcg/h
1.2.5 20 mcg/h
1.3 Global Buprenorphine Transdermal Patches Market Size by Type
1.3.1 Global Buprenorphine Transdermal Patches Market Size Overview by Type (2018-2029)
1.3.2 Global Buprenorphine Transdermal Patches Historic Market Size Review by Type (2018-2023)
1.3.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Buprenorphine Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.2 Europe Buprenorphine Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Buprenorphine Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Buprenorphine Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Buprenorphine Transdermal Patches Sales Breakdown by Type (2018-2023)
2 Global Buprenorphine Transdermal Patches Market Competition by Company
2.1 Global Top Players by Buprenorphine Transdermal Patches Sales (2018-2023)
2.2 Global Top Players by Buprenorphine Transdermal Patches Revenue (2018-2023)
2.3 Global Top Players by Buprenorphine Transdermal Patches Price (2018-2023)
2.4 Global Top Manufacturers Buprenorphine Transdermal Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Buprenorphine Transdermal Patches Market Competitive Situation and Trends
2.5.1 Buprenorphine Transdermal Patches Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Buprenorphine Transdermal Patches Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Buprenorphine Transdermal Patches as of 2022)
2.7 Date of Key Manufacturers Enter into Buprenorphine Transdermal Patches Market
2.8 Key Manufacturers Buprenorphine Transdermal Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Buprenorphine Transdermal Patches Status and Outlook by Region
3.1 Global Buprenorphine Transdermal Patches Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Buprenorphine Transdermal Patches Historic Market Size by Region
3.2.1 Global Buprenorphine Transdermal Patches Sales in Volume by Region (2018-2023)
3.2.2 Global Buprenorphine Transdermal Patches Sales in Value by Region (2018-2023)
3.2.3 Global Buprenorphine Transdermal Patches Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Region
3.3.1 Global Buprenorphine Transdermal Patches Sales in Volume by Region (2024-2029)
3.3.2 Global Buprenorphine Transdermal Patches Sales in Value by Region (2024-2029)
3.3.3 Global Buprenorphine Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Buprenorphine Transdermal Patches by Application
4.1 Buprenorphine Transdermal Patches Market Segment by Application
4.1.1 Relieve Cancer Pain
4.1.2 Other
4.2 Global Buprenorphine Transdermal Patches Market Size by Application
4.2.1 Global Buprenorphine Transdermal Patches Market Size Overview by Application (2018-2029)
4.2.2 Global Buprenorphine Transdermal Patches Historic Market Size Review by Application (2018-2023)
4.2.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Buprenorphine Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.2 Europe Buprenorphine Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Buprenorphine Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Buprenorphine Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Buprenorphine Transdermal Patches Sales Breakdown by Application (2018-2023)
5 North America Buprenorphine Transdermal Patches by Country
5.1 North America Buprenorphine Transdermal Patches Historic Market Size by Country
5.1.1 North America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Buprenorphine Transdermal Patches Sales in Volume by Country (2018-2023)
5.1.3 North America Buprenorphine Transdermal Patches Sales in Value by Country (2018-2023)
5.2 North America Buprenorphine Transdermal Patches Forecasted Market Size by Country
5.2.1 North America Buprenorphine Transdermal Patches Sales in Volume by Country (2024-2029)
5.2.2 North America Buprenorphine Transdermal Patches Sales in Value by Country (2024-2029)
6 Europe Buprenorphine Transdermal Patches by Country
6.1 Europe Buprenorphine Transdermal Patches Historic Market Size by Country
6.1.1 Europe Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Buprenorphine Transdermal Patches Sales in Volume by Country (2018-2023)
6.1.3 Europe Buprenorphine Transdermal Patches Sales in Value by Country (2018-2023)
6.2 Europe Buprenorphine Transdermal Patches Forecasted Market Size by Country
6.2.1 Europe Buprenorphine Transdermal Patches Sales in Volume by Country (2024-2029)
6.2.2 Europe Buprenorphine Transdermal Patches Sales in Value by Country (2024-2029)
7 Asia-Pacific Buprenorphine Transdermal Patches by Region
7.1 Asia-Pacific Buprenorphine Transdermal Patches Historic Market Size by Region
7.1.1 Asia-Pacific Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Buprenorphine Transdermal Patches Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Buprenorphine Transdermal Patches Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Buprenorphine Transdermal Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Buprenorphine Transdermal Patches Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Buprenorphine Transdermal Patches Sales in Value by Region (2024-2029)
8 Latin America Buprenorphine Transdermal Patches by Country
8.1 Latin America Buprenorphine Transdermal Patches Historic Market Size by Country
8.1.1 Latin America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Buprenorphine Transdermal Patches Sales in Volume by Country (2018-2023)
8.1.3 Latin America Buprenorphine Transdermal Patches Sales in Value by Country (2018-2023)
8.2 Latin America Buprenorphine Transdermal Patches Forecasted Market Size by Country
8.2.1 Latin America Buprenorphine Transdermal Patches Sales in Volume by Country (2024-2029)
8.2.2 Latin America Buprenorphine Transdermal Patches Sales in Value by Country (2024-2029)
9 Middle East and Africa Buprenorphine Transdermal Patches by Country
9.1 Middle East and Africa Buprenorphine Transdermal Patches Historic Market Size by Country
9.1.1 Middle East and Africa Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Buprenorphine Transdermal Patches Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Buprenorphine Transdermal Patches Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Buprenorphine Transdermal Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Buprenorphine Transdermal Patches Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Buprenorphine Transdermal Patches Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Grunenthal
10.1.1 Grunenthal Company Information
10.1.2 Grunenthal Introduction and Business Overview
10.1.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Grunenthal Buprenorphine Transdermal Patches Products Offered
10.1.5 Grunenthal Recent Development
10.2 PurduePharma
10.2.1 PurduePharma Company Information
10.2.2 PurduePharma Introduction and Business Overview
10.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.2.4 PurduePharma Buprenorphine Transdermal Patches Products Offered
10.2.5 PurduePharma Recent Development
10.3 Luye Pharma
10.3.1 Luye Pharma Company Information
10.3.2 Luye Pharma Introduction and Business Overview
10.3.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Luye Pharma Buprenorphine Transdermal Patches Products Offered
10.3.5 Luye Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Buprenorphine Transdermal Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Buprenorphine Transdermal Patches Industrial Chain Analysis
11.4 Buprenorphine Transdermal Patches Market Dynamics
11.4.1 Buprenorphine Transdermal Patches Industry Trends
11.4.2 Buprenorphine Transdermal Patches Market Drivers
11.4.3 Buprenorphine Transdermal Patches Market Challenges
11.4.4 Buprenorphine Transdermal Patches Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Buprenorphine Transdermal Patches Distributors
12.3 Buprenorphine Transdermal Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
